Canaccord Genuity Upgrades Belden to Buy, Raises Price Target to $68
Canaccord Genuity analyst Jed Dorsheimer upgrades Belden (NYSE:BDC) from Hold to Buy and raises the price target from $53 to $68.
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
Belden Highlights Q3 Product Launches, Including Products In Cable, Connectivity, Networking & Software
Belden Inc. (NYSE:BDC), a leading global supplier of specialty networking solutions, continues to offer its customers more options to deliver robust performance, withstand extreme environments and maximize space
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 119 companies set new 52-week highs.
Goldman Sachs Maintains Sell on Belden, Raises Price Target to $46
Goldman Sachs maintains Belden (NYSE:BDC) with a Sell and raises the price target from $39 to $46.
Belden Shares Skyrocket After Q2 Earnings Beat, Revenue Growth, Raised FY21 Outlook
Belden Inc. (NYSE:BDC) reported second-quarter revenue increased 40.7% year-over-year to $601.97 million, beating the consensus of $542.76 million. Enterprise Solutions…
Belden: Q2 Earnings Insights
Shares of Belden (NYSE:BDC) were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share were up 163.04% year over year to $1.21, which beat the estimate of $0.93.
Belden Q2 EPS $1.21 Beats $0.93 Estimate, Sales $601.97M Beat $542.76M Estimate
Belden (NYSE:BDC) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $0.93 by 30.11 percent. This is a 163.04 percent increase over earnings of $0.46 per share from the same
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.